1. Home
  2. GAMB vs PBYI Comparison

GAMB vs PBYI Comparison

Compare GAMB & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAMB
  • PBYI
  • Stock Information
  • Founded
  • GAMB 2006
  • PBYI 2010
  • Country
  • GAMB Jersey
  • PBYI United States
  • Employees
  • GAMB N/A
  • PBYI N/A
  • Industry
  • GAMB Services-Misc. Amusement & Recreation
  • PBYI Biotechnology: Pharmaceutical Preparations
  • Sector
  • GAMB Consumer Discretionary
  • PBYI Health Care
  • Exchange
  • GAMB Nasdaq
  • PBYI Nasdaq
  • Market Cap
  • GAMB 273.9M
  • PBYI 263.4M
  • IPO Year
  • GAMB 2021
  • PBYI N/A
  • Fundamental
  • Price
  • GAMB $7.13
  • PBYI $5.10
  • Analyst Decision
  • GAMB Strong Buy
  • PBYI Strong Buy
  • Analyst Count
  • GAMB 8
  • PBYI 1
  • Target Price
  • GAMB $15.13
  • PBYI $7.00
  • AVG Volume (30 Days)
  • GAMB 737.9K
  • PBYI 426.7K
  • Earning Date
  • GAMB 11-13-2025
  • PBYI 11-06-2025
  • Dividend Yield
  • GAMB N/A
  • PBYI N/A
  • EPS Growth
  • GAMB N/A
  • PBYI 434.29
  • EPS
  • GAMB 0.40
  • PBYI 0.97
  • Revenue
  • GAMB $147,655,000.00
  • PBYI $238,062,000.00
  • Revenue This Year
  • GAMB $38.41
  • PBYI N/A
  • Revenue Next Year
  • GAMB $11.58
  • PBYI N/A
  • P/E Ratio
  • GAMB $17.99
  • PBYI $5.24
  • Revenue Growth
  • GAMB 27.57
  • PBYI 8.63
  • 52 Week Low
  • GAMB $7.03
  • PBYI $2.32
  • 52 Week High
  • GAMB $17.14
  • PBYI $6.07
  • Technical
  • Relative Strength Index (RSI)
  • GAMB 32.14
  • PBYI 49.66
  • Support Level
  • GAMB $7.55
  • PBYI $5.14
  • Resistance Level
  • GAMB $7.84
  • PBYI $5.52
  • Average True Range (ATR)
  • GAMB 0.26
  • PBYI 0.27
  • MACD
  • GAMB -0.02
  • PBYI -0.03
  • Stochastic Oscillator
  • GAMB 10.87
  • PBYI 13.33

About GAMB Gambling.com Group Limited

Gambling.com Group Ltd is a multi-award-winning performance marketing company and a provider of digital marketing services in the online gambling industry. Its principal focus is on online casinos online sports betting and the fantasy sports industry. It generates revenue by referring online gamblers to online gambling operators.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: